|
Volumn 3, Issue 5, 1996, Pages 317-319
|
Drug targeting in cancer therapy: The magic bullet, what next?
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTHRACYCLINE;
ANTINEOPLASTIC AGENT;
CYTOTOXIC AGENT;
DOXORUBICIN;
IODINATED POPPYSEED OIL;
MACROGOL;
PACLITAXEL;
ACUTE LYMPHOCYTIC LEUKEMIA;
ANTINEOPLASTIC ACTIVITY;
BLOOD VESSEL PERMEABILITY;
CANCER CHEMOTHERAPY;
CANCER SURVIVAL;
CELL PROLIFERATION;
CLINICAL TRIAL;
DRUG FORMULATION;
DRUG TARGETING;
EDITORIAL;
HUMAN;
INTRAARTERIAL DRUG ADMINISTRATION;
LIVER CANCER;
PRIORITY JOURNAL;
SIGNAL TRANSDUCTION;
SOLID TUMOR;
|
EID: 0030044935
PISSN: 1061186X
EISSN: None
Source Type: Journal
DOI: 10.3109/10611869608996823 Document Type: Editorial |
Times cited : (32)
|
References (0)
|